Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
ILMNIllumina, Inc.
FinDog View：Bullish
| Metric | GILD | ILMN |
|---|
| Close | 150.43 | 276.67 |
| Market Cap | $187B | $42.0B |
| 1M | +4.67% | +34.01% |
| P/E (TTM) | — | 50.9 |
| Forward P/E | 22.0 | 42.1 |
| P/E 5-Yr Percentile | — | 98 |
| P/S | 6.2 | 9.4 |
| P/B | 15.9 | 14.8 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $7.8B | $1.2B |
| Revenue YoY | +10.2% | +9.4% |
| Gross Margin | 79.8% | 66.4% |
| Latest Quarter EPS | -8.45 | 1.35 |
| Avg Post-Earnings Move | ±3.8% | ±8.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.94% | 1.29% |
| 90-Day Net Insider Buying | −$15.7M | — |
GILD · Revenue, Last 8 Quarters ($B)
ILMN · Revenue, Last 8 Quarters ($B)
